tiprankstipranks
Advertisement
Advertisement
ShiraTronics Emphasizes Migraine as Key Women’s Health and MedTech Focus
PremiumPrivate CompaniesShiraTronics Emphasizes Migraine as Key Women’s Health and MedTech Focus
22d ago
ShiraTronics Emphasizes Migraine Burden in Women’s Health Strategy
Premium
Private Companies
ShiraTronics Emphasizes Migraine Burden in Women’s Health Strategy
23d ago
ShiraTronics – Weekly Recap
Premium
Private Companies
ShiraTronics – Weekly Recap
27d ago
ShiraTronics Highlights Chronic Migraine Neuromodulation Efforts and Industry Visibility
PremiumPrivate CompaniesShiraTronics Highlights Chronic Migraine Neuromodulation Efforts and Industry Visibility
1M ago
ShiraTronics – Weekly Recap
Premium
Private Companies
ShiraTronics – Weekly Recap
2M ago
ShiraTronics Targets Chronic Migraine Insights at 2026 Neurology Meeting
Premium
Private Companies
ShiraTronics Targets Chronic Migraine Insights at 2026 Neurology Meeting
2M ago
ShiraTronics Highlights Evidence-Driven Neuromodulation Strategy for Chronic Migraine in Latest Update
PremiumPrivate CompaniesShiraTronics Highlights Evidence-Driven Neuromodulation Strategy for Chronic Migraine in Latest Update
3M ago
ShiraTronics Emphasizes Evidence-Driven Neuromodulation Strategy for Chronic Migraine
Premium
Private Companies
ShiraTronics Emphasizes Evidence-Driven Neuromodulation Strategy for Chronic Migraine
3M ago
ShiraTronics Emphasizes Evidence-Driven Neuromodulation Strategy for Chronic Migraine
Premium
Private Companies
ShiraTronics Emphasizes Evidence-Driven Neuromodulation Strategy for Chronic Migraine
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100